| Name | 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione |
|---|---|
| Synonyms |
DMT-2'-OMe-U
5'-O-DMT-2'-O-METHYL-URIDINE 5'-DMT 2'-O-methyl uridine 2'-O-methyl-5"-O-dimethoxytrityl uridine HG1364 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-uridine 2'-O-Methyl-5'-O-DMT-Uridine;DMT-2'-OMe-U |
| Description | 5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C31H32N2O8 |
|---|---|
| Molecular Weight | 560.59 |
| Exact Mass | 560.21600 |
| PSA | 121.24000 |
| LogP | 2.83580 |
| Appearance | Powder | White to Pale Yellow |
| Storage condition | Store dry at 2-8°C |
|
~65%
103285-22-9 |
| Literature: Buettner, Lea; Seikowski, Jan; Wawrzyniak, Katarzyna; Ochmann, Anne; Hoebartner, Claudia Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 20 p. 6171 - 6180 |
|
~99%
103285-22-9 |
| Literature: ISIS Pharmaceuticals, Inc. Patent: US5914396 A1, 1999 ; |
|
~90%
103285-22-9 |
| Literature: Barbeyron, Renaud; Wengel, Jesper; Vasseur, Jean-Jacques; Smietana, Michael Monatshefte fur Chemie, 2013 , vol. 144, # 4 p. 495 - 500 |
|
~%
103285-22-9 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 20 p. 6171 - 6180 |
|
~%
103285-22-9 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 20 p. 6171 - 6180 |